Kewaunee Scientific (NASDAQ:KEQU) Issues Quarterly Earnings Results

Kewaunee Scientific (NASDAQ:KEQU) posted its quarterly earnings data on Tuesday. The technology company reported $999.00 earnings per share for the quarter, Zacks reports. Kewaunee Scientific had a return on equity of 18.09% and a net margin of 3.85%.

Kewaunee Scientific Price Performance

Shares of NASDAQ:KEQU traded down $1.33 during trading on Tuesday, reaching $35.73. 13,786 shares of the company traded hands, compared to its average volume of 4,655. The company’s 50 day moving average is $37.70 and its two-hundred day moving average is $38.09. The firm has a market capitalization of $102.55 million, a PE ratio of 9.60 and a beta of 0.70. The company has a quick ratio of 1.45, a current ratio of 2.12 and a debt-to-equity ratio of 0.58. Kewaunee Scientific has a 52 week low of $33.70 and a 52 week high of $60.89.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Bank of America Corp DE lifted its position in Kewaunee Scientific by 2,605.9% during the fourth quarter. Bank of America Corp DE now owns 460 shares of the technology company’s stock worth $28,000 after purchasing an additional 443 shares during the period. US Bancorp DE increased its holdings in Kewaunee Scientific by 80.0% in the 3rd quarter. US Bancorp DE now owns 900 shares of the technology company’s stock valued at $38,000 after buying an additional 400 shares during the period. Raymond James Financial Inc. acquired a new position in shares of Kewaunee Scientific in the 2nd quarter valued at approximately $60,000. Barclays PLC acquired a new position in shares of Kewaunee Scientific in the 4th quarter valued at approximately $92,000. Finally, Jane Street Group LLC lifted its holdings in shares of Kewaunee Scientific by 65.8% during the 1st quarter. Jane Street Group LLC now owns 8,052 shares of the technology company’s stock worth $317,000 after acquiring an additional 3,196 shares during the period. Institutional investors and hedge funds own 32.69% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “hold (c)” rating on shares of Kewaunee Scientific in a research note on Thursday, April 2nd. One research analyst has rated the stock with a Hold rating, According to MarketBeat, Kewaunee Scientific has a consensus rating of “Hold”.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation (NASDAQ:KEQU) is a global designer and manufacturer of scientific laboratory furniture, casework, fume hoods, containment solutions and related equipment. With roots dating back more than a century, the company develops integrated lab environments for research facilities, universities, biopharma companies, healthcare providers and government laboratories. Its product portfolio encompasses modular and custom casework, workstations, shelving systems, steel and epoxy resin solutions, as well as advanced ventilation and water management systems.

The company operates primary manufacturing facilities in Fitchburg, Wisconsin, supported by regional distribution and service centers in North America, Europe and Asia.